VWM
TMDX icon

Vermillion Wealth Management’s Transmedics TMDX Stock Holding History

Vermillion Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$298 – 2370
2026
Q1 		$298 Buy
+3
New +$391 ﹤0.01% 1184

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vermillion Wealth Management's TMDX Position: Q2 2026 in Review

Vermillion Wealth Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 3 shares — an estimated $298 sold.

Vermillion Wealth Management first reported a position in TMDX in Q1 2026 and held it in 1 quarter. The position peaked at $298 in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Vermillion Wealth Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Vermillion Wealth Management sold 3 Transmedics shares in Q2 2026, an estimated $298.
  • Vermillion Wealth Management first reported a position in Transmedics in Q1 2026 and held it in 1 quarter.
  • Vermillion Wealth Management's Transmedics position peaked at $298 in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.